Sagimet Biosciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

SAN MATEO, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company …

Do you trust this headline?

Based on recent headline ratings, 86% of this readership currently trusts the local media, which has an average score of 84% regionally and is currently trending positivepositive.

86%

Media Trust Score